Skip to main content
. 2015 Jul 20;128(14):1969–1976. doi: 10.4103/0366-6999.160566

Table 2.

Worldwide reports of the NDM cases

Genotyping Related diseases Antibiotic therapy Clinical outcomes Reference
NDM-1 Recurrent pyelonephritis ATM, CL Fever and abdominal pain resolved within 48 h after administration of antibiotics [36]
NDM-1 Periappendicular abscess CIP, MTZ, TZP Good clinical response [69]
NDM-1 Crush trauma CIP, CC, MEN, VA, CL, TGC He finally succumbed from refractory circulatory shock* [71]
NDM-1 Persistent nonbloody diarrhea unspecified encephalitis IMP, VA, MTZ, CL, CHL Her condition worsened and she died [38]
NDM-3 Community-acquired uncomplicated cystitis F/M Resolve all clinical symptoms [4]
NDM-1 Calciphylaxis TZP, TGC, CIP, CL, MEM and TEC Six months after initial presentation, the patient remains clinically stable [58]
NDM-1 Extensive electrical burns MEM, cotrimoxazole, CL, TEC His fever defervesced, blood cultures became sterile. His wounds had healed and no MDR were detected [8]

*The critically ill patient got acute respiratory muscle weakness and apnea that were induced by colistin neurotoxicity; The final diagnosis of this patient was toxic metabolic leukoencephalopathy, probably related to sepsis. TEC: Teicoplanin; TGC: Tigecycline; MEN: Meropenem; CIP: Ciprofloxacin; VA: Vancomycin; TZP: Piperacillin/tazobactam; ATM: Aztreonam; CL: Colistin; MTZ: Metronidazole; CHL: Chloramphenicol; F/M: Nitrofurantoin; CC: Clindamycin; IMP: Imipenem; Co-trimoxazole: Trimethoprim-sulfamethoxazole; NDM: New Delhi metallo-β-lactamase.